FDA-Approved Peanut Allergy Immunotherapy Exits Market
(MedPage Today) -- Not many allergists are mourning the exit of the first and only FDA-approved oral immunotherapy (OIT) product--peanut allergy treatment Palforzia--from the market.
The standardized peanut protein product had been approved...
Read more »